Orthofix Medical Inc. (OFIX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseOFIX / S&P -20.31% / 15.20% |
LoseOFIX / S&P 2.99% / 15.00% |
LoseOFIX / S&P -51.74% / 50.40% |
| 2026-Q10/3 |
LoseOFIX / S&P -24.34% / -4.33% |
LoseOFIX / S&P 2.59% / 11.30% |
LoseOFIX / S&P -59.35% / 27.70% |
| 2025-Q41/3 |
WinOFIX / S&P 3.55% / 2.65% |
LoseOFIX / S&P 2.85% / 9.00% |
LoseOFIX / S&P -29.18% / 13.40% |
| 2025-Q31/3 |
WinOFIX / S&P 31.30% / 8.12% |
LoseOFIX / S&P 4.31% / 4.61% |
LoseOFIX / S&P -3.19% / 13.45% |
| 2025-Q21/3 |
LoseOFIX / S&P -31.64% / 10.94% |
WinOFIX / S&P 4.84% / 4.83% |
LoseOFIX / S&P -0.63% / 10.63% |
| 2025-Q11/3 |
LoseOFIX / S&P -6.59% / -4.27% |
WinOFIX / S&P 5.85% / 4.98% |
LoseOFIX / S&P 9.17% / 10.57% |
| 2024-Q42/3 |
WinOFIX / S&P 11.78% / 2.41% |
WinOFIX / S&P 7.08% / 5.25% |
LoseOFIX / S&P -20.53% / 6.15% |
| 2024-Q32/3 |
WinOFIX / S&P 17.80% / 5.89% |
WinOFIX / S&P 17.32% / 5.89% |
LoseOFIX / S&P -19.74% / 6.11% |
| 2024-Q21/3 |
LoseOFIX / S&P -8.68% / 4.28% |
WinOFIX / S&P 28.94% / 5.38% |
LoseOFIX / S&P -12.84% / 5.12% |
| 2024-Q12/3 |
LoseOFIX / S&P 7.72% / 10.56% |
WinOFIX / S&P 43.54% / 5.71% |
WinOFIX / S&P 36.84% / 5.59% |
| 2023-Q42/3 |
LoseOFIX / S&P 4.82% / 11.69% |
WinOFIX / S&P 62.06% / 6.81% |
WinOFIX / S&P 322.45% / 7.78% |
| 2023-Q32/3 |
LoseOFIX / S&P -28.79% / -3.27% |
WinOFIX / S&P 44.20% / 7.52% |
WinOFIX / S&P 69.57% / -5.03% |
| 2023-Q22/3 |
LoseOFIX / S&P 7.82% / 8.74% |
WinOFIX / S&P 29.54% / 9.50% |
WinOFIX / S&P 120.48% / -8.57% |
| 2023-Q12/3 |
LoseOFIX / S&P -18.41% / 7.50% |
WinOFIX / S&P 13.80% / 10.77% |
WinOFIX / S&P 48.80% / -15.69% |
| 2022-Q40/3 |
LoseOFIX / S&P 7.43% / 7.56% |
LoseOFIX / S&P -0.81% / 11.88% |
LoseOFIX / S&P -43.68% / -17.99% |
| 2022-Q31/3 |
LoseOFIX / S&P -18.82% / -4.88% |
LoseOFIX / S&P 1.43% / 13.47% |
WinOFIX / S&P 318.18% / -1.41% |
| 2022-Q21/3 |
LoseOFIX / S&P -28.01% / -16.10% |
LoseOFIX / S&P 1.40% / 13.71% |
WinOFIX / S&P 295.24% / 11.04% |
| 2022-Q11/3 |
WinOFIX / S&P 5.18% / -4.60% |
LoseOFIX / S&P 14.23% / 15.97% |
LoseOFIX / S&P 10.67% / 42.23% |
| 2021-Q40/3 |
LoseOFIX / S&P -18.44% / 11.03% |
LoseOFIX / S&P 14.25% / 15.00% |
LoseOFIX / S&P -1550.00% / 96.40% |
| 2021-Q31/3 |
LoseOFIX / S&P -4.96% / 0.58% |
WinOFIX / S&P 11.35% / 10.77% |
LoseOFIX / S&P -145.08% / 69.42% |
| 2021-Q21/3 |
LoseOFIX / S&P -7.47% / 8.55% |
WinOFIX / S&P 10.33% / 6.58% |
LoseOFIX / S&P -63.79% / 51.81% |
| 2021-Q11/3 |
LoseOFIX / S&P 0.86% / 6.17% |
LoseOFIX / S&P -10.61% / -1.06% |
WinOFIX / S&P 552.17% / 7.39% |
| 2020-Q41/3 |
WinOFIX / S&P 38.02% / 12.15% |
LoseOFIX / S&P -11.61% / -3.72% |
LoseOFIX / S&P -108.00% / -33.42% |
| 2020-Q30/3 |
LoseOFIX / S&P -2.69% / 8.93% |
LoseOFIX / S&P -10.69% / -2.04% |
LoseOFIX / S&P -173.49% / -27.10% |
| 2020-Q20/3 |
LoseOFIX / S&P 14.24% / 20.54% |
LoseOFIX / S&P -9.79% / -0.46% |
LoseOFIX / S&P -382.93% / -27.11% |
| 2020-Q10/3 |
LoseOFIX / S&P -39.35% / -19.60% |
LoseOFIX / S&P 0.49% / 3.47% |
LoseOFIX / S&P -146.94% / -14.75% |
| 2019-Q40/3 |
LoseOFIX / S&P -12.90% / 9.07% |
LoseOFIX / S&P 1.53% / 5.36% |
LoseOFIX / S&P -311.27% / 2.99% |
| 2019-Q30/3 |
LoseOFIX / S&P 0.26% / 1.70% |
LoseOFIX / S&P 2.38% / 5.02% |
LoseOFIX / S&P -588.24% / 0.21% |
| 2019-Q20/3 |
LoseOFIX / S&P -6.26% / 4.30% |
LoseOFIX / S&P 3.47% / 6.64% |
LoseOFIX / S&P -31.67% / 8.65% |
| 2019-Q10/3 |
LoseOFIX / S&P 7.47% / 13.65% |
LoseOFIX / S&P 3.10% / 8.12% |
LoseOFIX / S&P -35.53% / 14.29% |
| 2018-Q42/3 |
WinOFIX / S&P -9.20% / -13.52% |
LoseOFIX / S&P 4.43% / 9.05% |
WinOFIX / S&P 108.82% / 18.23% |
| 2018-Q31/3 |
LoseOFIX / S&P 1.74% / 7.71% |
LoseOFIX / S&P 5.50% / 10.21% |
WinOFIX / S&P 325.00% / 19.06% |
| 2018-Q21/3 |
LoseOFIX / S&P -3.33% / 3.43% |
LoseOFIX / S&P 5.66% / 9.03% |
WinOFIX / S&P 39.53% / 14.46% |
| 2018-Q11/3 |
WinOFIX / S&P 7.46% / -0.76% |
LoseOFIX / S&P 6.27% / 7.68% |
LoseOFIX / S&P -500.00% / 12.46% |
| 2017-Q42/3 |
WinOFIX / S&P 15.77% / 6.64% |
LoseOFIX / S&P 5.87% / 7.03% |
WinOFIX / S&P 112.50% / 13.82% |
| 2017-Q30/3 |
LoseOFIX / S&P 1.66% / 4.48% |
LoseOFIX / S&P 4.83% / 5.68% |
LoseOFIX / S&P -84.31% / 17.57% |
| 2017-Q21/3 |
WinOFIX / S&P 21.83% / 3.09% |
LoseOFIX / S&P 2.49% / 4.83% |
LoseOFIX / S&P -530.00% / 17.74% |
| 2017-Q10/3 |
LoseOFIX / S&P 5.45% / 6.07% |
LoseOFIX / S&P 2.08% / 3.67% |
LoseOFIX / S&P -138.00% / 13.32% |
| 2016-Q41/3 |
LoseOFIX / S&P -15.41% / 3.82% |
WinOFIX / S&P 3.35% / 2.09% |
LoseOFIX / S&P -206.67% / 7.05% |
| 2016-Q31/3 |
LoseOFIX / S&P 0.87% / 3.85% |
WinOFIX / S&P 3.50% / 0.20% |
LoseOFIX / S&P -179.69% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | OFIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -35.71% | 20.78% |
| Annualized return | -35.71% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | OFIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -77.49% | 83.14% |
| Annualized return | -25.79% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | OFIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -78.84% | 319.30% |
| Annualized return | -14.39% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |